+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Abbott Point of Care Inc - Product Pipeline Analysis, 2019 Update

  • ID: 4267307
  • Company Profile
  • November 2019
  • 32 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • AmbiMed Inc
  • AutoGenomics Inc
  • MORE
Summary

Abbott Point of Care Inc (Abbott Point), a subsidiary of Abbott Laboratories, is a medical device company that offers diagnostic products. The company manufactures, develops, and distributes medical diagnostic and data management products for in-vitro diagnostic and healthcare markets. Its products comprise handheld blood analyzers, cardiac markers, lactate, blood gases, electrolytes, lab information systems, electronic medical recording systems, and automated clinical chemistry systems. Abbott Point provides value assignment sheets, software and license keys, tutorial and training materials, and POC testing devices, among others. The company's services include POC solutions, implementation and training services, technical support services, and laboratory services. It operates in the UK and Canada. Abbott Point is headquartered in Princeton, New Jersey, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Abbott Point of Care Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • AmbiMed Inc
  • AutoGenomics Inc
  • MORE
  • Abbott Point of Care Inc Company Overview
  • Abbott Point of Care Inc Company Snapshot
  • Abbott Point of Care Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Abbott Point of Care Inc - Pipeline Analysis Overview
  • Abbott Point of Care Inc - Key Facts
  • Abbott Point of Care Inc - Major Products and Services
  • Abbott Point of Care Inc Pipeline Products by Development Stage
  • Abbott Point of Care Inc Ongoing Clinical Trials by Trial Status
  • Abbott Point of Care Inc Pipeline Products Overview
  • i-Stat - Traumatic Brain Injury Assay
  • i-Stat - Traumatic Brain Injury Assay Product Overview
  • i-Stat - Traumatic Brain Injury Assay Clinical Trial
  • i-STAT Alinity - Cancer
  • i-STAT Alinity - Cancer Product Overview
  • i-STAT Alinity - Infectious Diseases
  • i-STAT Alinity - Infectious Diseases Product Overview
  • i-STAT TnI-Nx
  • i-STAT TnI-Nx Product Overview
  • Abbott Point of Care Inc - Key Competitors
  • Abbott Point of Care Inc - Key Employees
  • Abbott Point of Care Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Recent Developments
  • Abbott Point of Care Inc, Recent Developments
  • Aug 27, 2019: Study finds Abbott’s blood test could identify mild TBI
  • May 02, 2019: Abbott forms multidisciplinary alliance to trial blood test for concussions
  • Apr 30, 2019: Abbott, the U.S. Department of Defense and TRACK-TBI Partner to Study Point-of-Care Blood Test for Concussions
  • Apr 09, 2018: i-STAT in the Medical Tent
  • Nov 30, 2016: Abbott Announces CE Mark For i-STAT Alinity, a Pioneering, Handheld Blood Testing Platform
  • Mar 09, 2016: Abbott, Hennepin County Medical Center and University of Minnesota Collaborate to Launch the Nation's Largest, Single-Center Prospective Study on Concussion and Traumatic Brain Injury
  • Apr 30, 2015: Abbott's First-Of-Its-Kind Blood Test To Aid In Detecting Early Pregnancy Could Help Doctors Make Faster Treatment Decisions For Women
  • Mar 29, 2011: Abbott Receives FDA Approval For i-STAT 1 Wireless Point Of Care Testing System
  • Jan 19, 2009: FDA Grants CLIA Waiver To Abbott To Use Five Additional Cartridges On The i-STAT Handheld Blood Analyzer
  • Apr 10, 2008: MEDRAD To Distribute Abbott’s Portable Blood Analyzer
  • Appendix
  • Methodology
  • About the Publisher
  • Contact Us
  • Disclaimer
List of Tables
  • Abbott Point of Care Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Abbott Point of Care Inc Pipeline Products by Equipment Type
  • Abbott Point of Care Inc Pipeline Products by Indication
  • Abbott Point of Care Inc Ongoing Clinical Trials by Trial Status
  • Abbott Point of Care Inc, Key Facts
  • Abbott Point of Care Inc, Major Products and Services
  • Abbott Point of Care Inc Number of Pipeline Products by Development Stage
  • Abbott Point of Care Inc Pipeline Products Summary by Development Stage
  • Abbott Point of Care Inc Ongoing Clinical Trials by Trial Status
  • Abbott Point of Care Inc Ongoing Clinical Trials Summary
  • i-Stat - Traumatic Brain Injury Assay - Product Status
  • i-Stat - Traumatic Brain Injury Assay - Product Description
  • i-Stat - Traumatic Brain Injury Assay - Transforming Research and Clinical Knowledge in Traumatic Brain Injury
  • i-STAT Alinity - Cancer - Product Status
  • i-STAT Alinity - Cancer - Product Description
  • i-STAT Alinity - Infectious Diseases - Product Status
  • i-STAT Alinity - Infectious Diseases - Product Description
  • i-STAT TnI-Nx - Product Status
  • i-STAT TnI-Nx - Product Description
  • Abbott Point of Care Inc, Key Employees
  • Abbott Point of Care Inc, Other Locations
  • Glossary
List of Figures
  • Abbott Point of Care Inc Pipeline Products by Equipment Type
  • Abbott Point of Care Inc Pipeline Products by Development Stage
  • Abbott Point of Care Inc Ongoing Clinical Trials by Trial Status
Note: Product cover images may vary from those shown
3 of 3
  • AutoGenomics Inc
  • Aviva Systems Biology Corp
  • Haematologic Technologies Inc
  • AmbiMed Inc
Note: Product cover images may vary from those shown
Adroll
adroll